01 1ADC Therapeutics
01 1HUBA-1-3D-GAINACN3 MAB
01 1Switzerland
01 1Active
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37170
Submission : 2022-08-22
Status : Active
Type : II
20
Adc Therapeutics Sa, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HUBA-1-3D-GAINACN3 MAB, with a corresponding US DMF Number 37170.
Remarkably, this DMF maintains an Active status since its submission on August 22, 2022, highlighting commitment to regulatory compliance.
